Altre lingue Exagen Inc.

Azioni

XGN

US30068X1037

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 01/05/2024			Variaz. 5gg	Var. 1 gen.
1,36 ^USD	-1,83%		-1,45%	-31,66%

26/04	Exagen Inc. annuncia cambiamenti nel Consiglio di Amministrazione	CI
18/03	Exagen Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Exagen to Announce First Quarter 2024 Results on May 13, 2024	30/04
Exagen to Announce First Quarter 2024 Results on May 13, 2024	30/04
Exagen Inc. Announces Changes to the Board of Directors	29/04
Exagen Inc. Announces Changes to the Board of Directors	26/04
Exagen Inc. Announces Changes in Board of Directors	26/04
Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $13.8M, vs. Street Est of $11.6M	18/03
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results	18/03
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results	18/03
Exagen Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	18/03
Exagen Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	18/03
North American Morning Briefing : Investors -2-	18/03
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum	08/03
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum	08/03
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024	07/03
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	30/01
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance	07/01
Exagen Inc. Reaffirms Earnings Guidance for the Full Year Ended December 31, 2023	07/01
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance	07/01
Exagen Files $150 Million Mixed Shelf	20/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Exagen Inc.

Azioni

XGN

US30068X1037

Altre lingue

Filtri